Both in Biotechnology
Atara Biotherapeutics vs Pelthos Therapeutics
Over the past year ATRA returned −41.7% and PTHS returned −30.3%; their daily moves had a correlation of 0.04.
ATRA −41.7% PTHS −30.3%Growth of $1, one year, split-adjusted
| Metric | ATRA | PTHS |
|---|---|---|
| Price | $8.05 | $20.92 |
| Market cap | $80.8M | $80.1M |
| Today | −3.82% | −1.55% |
| 1 month | −12.5% | −15.4% |
| 6 months | +86.3% | −0.4% |
| Year to date | −55.5% | −32.5% |
| 1 year | −41.4% | — |
| Revenue growth (YoY) | −96.4% | — |
| Gross margin | 69.7% | 76.9% |
| Net margin | −767.3% | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | 13.0× | 1.8× |
| Net cash | $9.9M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 65.7% | 72.5% |
| Short % of float | 15.5% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).